XML 22 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation
 3 Months Ended
May 05, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
SHARE-BASED COMPENSATION
For the thirteen weeks ended May 5, 2018 and April 29, 2017, share-based compensation expense was $5.1 million and $5.8 million, respectively. As of May 5, 2018, approximately 7.0 million shares remain available for future grants of equity awards under our Amended and Restated 2012 Omnibus Stock and Incentive Plan, which was amended and restated effective June 22, 2017.
Restricted Stock Awards
Restricted stock awards vest in equal annual installments over a three-year period from the date of grant.
Restricted stock award activity for the thirteen weeks ended May 5, 2018 was as follows:

Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
2,328,259

 
$
13.08

Granted
1,695,950

 
9.85

Vested
(752,782
)
 
14.16

Forfeited
(51,576
)
 
13.15

Unvested, end of period
3,219,851

 
11.13


Performance-based Stock Units
For the thirteen weeks ended May 5, 2018, we granted performance-based restricted stock units (“PSUs”), contingent upon the achievement of Company-specific performance goals during the three fiscal years 2018-2020. Any units earned as a result of the achievement of this goal will vest 100% three years from the date of grant and will be settled in shares of our common stock.
Performance-based restricted stock unit activity for the thirteen weeks ended May 5, 2018 was as follows:
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
690,950

 
$
13.65

Granted
725,300

 
9.87

Vested
(186,782
)
 
13.08

Forfeited
(14,466
)
 
14.13

Unvested, end of period
1,215,002

 
11.41


 
Stock Option Awards
For the thirteen weeks ended May 5, 2018 and April 29, 2017, we did not grant any stock options.
Stock option activity for the thirteen weeks ended May 5, 2018 was as follows:
 
Number of
Options
 
Weighted
 Average
Exercise Price
Outstanding, beginning of period
368,745

 
$
12.36

Granted
—

 
—

Exercised
(5,050
)
 
7.40

Forfeited or expired
(85,000
)
 
13.72

Outstanding and exercisable at May 5, 2018
278,695

 
12.03